Exploring the Role of MicroRNAs in Cancer Progression

Thesis Abstract

Abstract
The dysregulation of microRNAs (miRNAs) has been widely implicated in various aspects of cancer progression. This thesis aims to explore the role of miRNAs in cancer progression, focusing on their impact on tumor development, metastasis, and therapeutic outcomes. The study delves into the intricate mechanisms by which miRNAs influence key cellular processes involved in cancer pathogenesis, such as proliferation, apoptosis, and angiogenesis. Chapter One provides a comprehensive introduction to the research topic, presenting the background of the study, problem statement, objectives, limitations, scope, significance, structure of the thesis, and definition of key terms. Chapter Two conducts an in-depth literature review, analyzing existing studies on the relationship between miRNAs and cancer progression. The review covers ten key aspects, including the mechanisms of miRNA dysregulation, the role of specific miRNAs in different cancer types, and the potential of miRNAs as diagnostic and therapeutic tools. Chapter Three outlines the research methodology employed in this study, detailing the experimental design, sample collection and analysis techniques, data interpretation methods, and statistical analysis procedures. The chapter includes eight key components, such as the selection criteria for miRNAs of interest, the cell culture models utilized, and the bioinformatic tools employed for data analysis. Chapter Four presents a detailed discussion of the research findings, highlighting the specific miRNAs identified as critical players in cancer progression and elucidating their functional roles in promoting or inhibiting tumor growth and metastasis. The chapter also explores the implications of these findings for potential therapeutic interventions targeting miRNAs in cancer treatment. Finally, Chapter Five offers a comprehensive conclusion and summary of the thesis, summarizing the key findings, discussing their significance in the context of current knowledge, and proposing future research directions in the field of miRNA-based cancer therapeutics. The abstract concludes with a reflection on the potential impact of this study on advancing our understanding of the role of miRNAs in cancer progression and improving clinical outcomes for cancer patients. In conclusion, this thesis contributes valuable insights into the complex interplay between miRNAs and cancer progression, shedding light on novel therapeutic targets and diagnostic biomarkers that hold promise for enhancing the management of cancer patients.